Rare lephants
Screener

Neurocrine Biosciences, Inc.

NBIX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Oct 15, 2026
3 Oct 7, 2026 FORM 3
8-K Sep 28, 2026 8-K
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
4 Sep 15, 2026 FORM 4
144 Sep 14, 2026
144 Sep 14, 2026
4 Sep 10, 2026 FORM 4
144 Sep 9, 2026
4 Sep 3, 2026 FORM 4
4 Aug 5, 2026 FORM 4
S-8 Jul 31, 2026 S-8
8-K/A Jul 31, 2026 8-K/A
10-Q Jul 31, 2026 10-Q
4 Jul 30, 2026 FORM 4
8-K Jul 30, 2026 8-K
SCHEDULE 13G/A Jul 27, 2026
← Newer Page 1 of 86 · 2133 filings Older →